Effect of CCR5-Δ32 heterozygosity on the risk of perinatal HIV-1 infection: A meta-analysis

Several studies have investigated whether heterozygosity for a 32-basepair deletion in the CC chemokine receptor 5 gene (CCR5-Delta32 ) affects susceptibility to perinatal HIV-1 infection, but results have been inconclusive. We performed a meta-analysis of published data from 11 studies of HIV-1 perinatally exposed children who were genotyped for the CCR5-Delta32 polymorphism. The crude overall HIV-1 infection rates, by simple data pooling, were 20% (one of five) amongCCR5-Delta32 homozygote children, 39% (131 of 335) among CCR5-Delta32 heterozygote children, and 40% (1408 of 3526) among wild-type CCR5 homozygote children. Compared with wild-type homozygotes, the random effects risk ratio for heterozygotes was 1.04 (95% confidence interval [CI], 0.92-1.17) among all children (N = 3861) and 1.03 (95% CI, 0.90-1.17) among those of European descent (n = 2890). Results were similar when adjusted for the available data on the CCR2-641 polymorphism (n = 1542). The meta-analysis clarifies that perinatal infection is not significantly altered by heterozygosity for CCR5-Delta32 in the child.

[1]  John P A Ioannidis,et al.  Commentary: meta-analysis of individual participants' data in genetic epidemiology. , 2002, American journal of epidemiology.

[2]  J. Ioannidis,et al.  Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. , 2002, AIDS research and human retroviruses.

[3]  H. Ullum,et al.  Effects of CCR5- 32, CCR2-64I, and SDF-1 3A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data , 2001, Annals of Internal Medicine.

[4]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[5]  J. Sterne,et al.  Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. , 2001, Journal of clinical epidemiology.

[6]  H. Sheppard,et al.  Homozygous and Heterozygous CCR5‐&Dgr;32 Genotypes Are Associated With Resistance to HIV Infection , 2001, Journal of acquired immune deficiency syndromes.

[7]  G. Scarlatti,et al.  HIV type 1 chemokine receptor usage in mother-to-child transmission. , 2001, AIDS research and human retroviruses.

[8]  R. Duggirala,et al.  Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus. , 2001, The Journal of infectious diseases.

[9]  S. Tognazzo,et al.  Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children. , 2001, The Journal of infectious diseases.

[10]  J. Goedert,et al.  Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. , 2001, The Journal of infectious diseases.

[11]  A. Kourtis,et al.  Understanding the timing of HIV transmission from mother to infant. , 2001, JAMA.

[12]  R. Nuccitelli,et al.  Chemokine receptor expression by human syncytiotrophoblast. , 2001, Journal of Reproductive Immunology.

[13]  J. Ioannidis,et al.  Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Mandaliya,et al.  Exposure to HIV-1 during delivery and mother-to-child transmission , 2000, AIDS.

[15]  L. Chieco‐Bianchi,et al.  Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission , 2000, AIDS.

[16]  P. Roques,et al.  HIV‐1 co‐receptor expression on trophoblastic cells from early placentas and permissivity to infection by several HIV‐1 primary isolates , 2000, Clinical and experimental immunology.

[17]  A. Mangano,et al.  Protective Effect of CCR2‐64I and Not of CCR5‐&Dgr;32 and SDF1‐3′A in Pediatric HIV‐1 Infection , 2000, Journal of acquired immune deficiency syndromes.

[18]  A. Mangano,et al.  Protective effect of CCR2-64I and not of CCR5-Δ32 and SDF1-3'A in pediatric HIV-1 infection , 2000 .

[19]  C. Cancrini,et al.  Prognostic Value of a CCR5 Defective Allele in Pediatric HIV-1 Infection , 2000, Molecular medicine.

[20]  B. Korber,et al.  A Polymorphism in the Regulatory Region of the CC-Chemokine Receptor 5 Gene Influences Perinatal Transmission of Human Immunodeficiency Virus Type 1 to African-American Infants , 1999, Journal of Virology.

[21]  H. Schuitemaker,et al.  CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection. , 1999, Journal of immunology.

[22]  R. Sirera,et al.  CCR5 Genotype and Human Immunodeficiency Virus Type 1 Infection in Perinatally Exposed Infants , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[23]  M. Newell,et al.  CCR5, vertical transmission of HIV-1, and disease progression. European Collaborative Study. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[24]  A. Heredia,et al.  CCR5 genotype and HIV-1 infection in perinatally-exposed infants. , 1999, The Journal of infection.

[25]  G. Zuccotti,et al.  Role of CCR5 chemokine receptor gene in vertical human immunodeficiency virus type 1 transmission and disease progression. , 1998, The Pediatric Infectious Disease Journal.

[26]  J. Ioannidis,et al.  Maternal cell-free viremia in the natural history of perinatal HIV-1 transmission: a meta-analysis. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[27]  C. Mandl,et al.  Possible influence of the mutant CCR5 allele on vertical transmission of HIV‐1 , 1998, Journal of medical virology.

[28]  D. Weissman,et al.  Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. , 1998, Journal of immunology.

[29]  L. Kalish,et al.  ccr5 Hiv-1 Vertical Transmission , 1998 .

[30]  C. Rouzioux,et al.  CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group. , 1998, JAMA.

[31]  Linqi Zhang,et al.  Distribution of CCR5Δ32 in Human Immunodeficiency Virus-Infected Children and Its Relationship to Disease Course , 1998, Clinical Diagnostic Laboratory Immunology.

[32]  L. Kalish,et al.  CCR5 HIV-1 vertical transmission. Women and Infants Transmission Study Group. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[33]  M. King,et al.  CCR5del32 in perinatal HIV-1 infection. , 1997, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology.

[34]  J. Hughes,et al.  Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[35]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.

[36]  H. Asada,et al.  Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. , 1997, The Journal of clinical investigation.

[37]  R. Doms,et al.  CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status. , 1997, The Journal of infectious diseases.

[38]  J J Goedert,et al.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.

[39]  Nancy Sullivan,et al.  CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro , 1997, The Journal of experimental medicine.

[40]  Steven M. Wolinsky,et al.  The role of a mutant CCR5 allele in HIV–1 transmission and disease progression , 1996, Nature Medicine.

[41]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[42]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[43]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[44]  R. Gelber,et al.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. , 1994, The New England journal of medicine.

[45]  J. Levy,et al.  Features of HIV-1 that could influence maternal-child transmission. , 1994, JAMA.

[46]  J. Albert,et al.  Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. , 1993, Virology.